KRISHNA MURTHY: Open Payments
NPI 1790725752 · PATTON, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$322 in 11 payments from 6 companies in 2025. Trend: 2023 $128 · 2024 $23 · 2025 $322
Food & beverage: $322
| Company | Payments | Amount |
|---|---|---|
| Axsome Therapeutics, Inc. | 1 | $125 |
| Teva Pharmaceuticals USA, Inc. | 3 | $61 |
| Otsuka America Pharmaceutical, Inc. | 3 | $47 |
| E.R. Squibb & Sons, L.L.C. | 2 | $33 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 1 | $28 |
| Neurocrine BioSciences, Inc. | 1 | $27 |
Products named: Auvelity, ABILIFY ASIMTUFII, UZEDY, COBENFY, CAPLYTA, INGREZZA, AUSTEDO XR.
Industry payments across CA — which companies pay providers there.
